Last quarter (Q4 2022), Arovella Therapeutics Limited's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Arovella Therapeutics Limited's net income was $―. See Arovella Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Total Revenue	$ ―	$ 295.81K	$ 257.35K	$ 532.69K	$ 1.22M	$ 425.86K
Cost of Revenue	$ ―	$ 207.06K	$ 222.75K	$ 200.97K	$ 199.69K	$ 185.62K
Gross Profit	$ ―	$ 88.75K	$ 34.60K	$ 331.72K	$ 1.02M	$ 240.24K
Operating Expense	$ ―	$ 7.69M	$ 4.70M	$ 5.13M	$ 3.38M	$ 6.35M
Operating Income	$ ―	$ -7.60M	$ -4.67M	$ -4.80M	$ -2.36M	$ -6.11M
Net Non Operating Interest Income Expense	$ ―	$ -190.88K	$ -26.75K	$ 22.24K	$ -94.26K	$ -174.50K
Other Income Expense	$ ―	$ -833.27K	$ -354.60K	$ -5.82M	$ -6.27M	$ -497.31K
Pretax Income	$ ―	$ -8.62M	$ -5.05M	$ -10.59M	$ -8.72M	$ -6.78M
Tax Provision	$ ―	$ 0.00	$ 0.00	$ -655.88K	$ -925.00K	$ -745.00K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -8.62M	$ -5.05M	$ -9.94M	$ -7.80M	$ -5.46M
Basic EPS	$ ―	$ -0.02	$ -0.02	$ -0.06	$ -0.07	$ ―
Diluted EPS	$ ―	$ -0.02	$ -0.02	$ -0.06	$ -0.07	$ ―
Basic Average Shares	$ ―	$ 549.62M	$ 330.89M	$ 167.91M	$ 116.36M	$ ―
Diluted Average Shares	$ ―	$ 549.62M	$ 330.89M	$ 167.91M	$ 116.36M	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income From Continuing And Discontinued Operation	$ ―	$ -8.62M	$ -5.05M	$ -9.94M	$ -7.80M	$ -5.46M
Normalized Income	$ ―	$ -7.79M	$ -3.79M	$ -4.34M	$ -2.16M	$ -5.53M
Interest Expense	$ ―	$ 194.72K	$ 33.29K	$ 6.57K	$ 125.06K	$ 177.03K
EBIT	$ ―	$ -8.43M	$ -5.01M	$ -10.58M	$ -8.59M	$ -6.60M
EBITDA	$ ―	$ -7.87M	$ -4.36M	$ -10.01M	$ -8.12M	$ -6.44M

Currency in USD

Arovella Therapeutics Limited Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing